428 related articles for article (PubMed ID: 25514380)
1. Imaging tumour hypoxia with positron emission tomography.
Fleming IN; Manavaki R; Blower PJ; West C; Williams KJ; Harris AL; Domarkas J; Lord S; Baldry C; Gilbert FJ
Br J Cancer; 2015 Jan; 112(2):238-50. PubMed ID: 25514380
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of hypoxia in cancer.
Challapalli A; Carroll L; Aboagye EO
Clin Transl Imaging; 2017; 5(3):225-253. PubMed ID: 28596947
[TBL] [Abstract][Full Text] [Related]
3. Current preclinical and clinical applications of hypoxia PET imaging using 2-nitroimidazoles.
Peeters SG; Zegers CM; Yaromina A; Van Elmpt W; Dubois L; Lambin P
Q J Nucl Med Mol Imaging; 2015 Mar; 59(1):39-57. PubMed ID: 25517080
[TBL] [Abstract][Full Text] [Related]
4. Molecular imaging of hypoxia.
Chitneni SK; Palmer GM; Zalutsky MR; Dewhirst MW
J Nucl Med; 2011 Feb; 52(2):165-8. PubMed ID: 21233176
[TBL] [Abstract][Full Text] [Related]
5. FMISO as a Biomarker for Clinical Radiation Oncology.
Zschaeck S; Steinbach J; Troost EG
Recent Results Cancer Res; 2016; 198():189-201. PubMed ID: 27318688
[TBL] [Abstract][Full Text] [Related]
6. From anatomical to biological target volumes: the role of PET in radiation treatment planning.
Schinagl DA; Kaanders JH; Oyen WJ
Cancer Imaging; 2006 Oct; 6(Spec No A):S107-16. PubMed ID: 17114062
[TBL] [Abstract][Full Text] [Related]
7. Molecular imaging of hypoxia with radiolabelled agents.
Mees G; Dierckx R; Vangestel C; Van de Wiele C
Eur J Nucl Med Mol Imaging; 2009 Oct; 36(10):1674-86. PubMed ID: 19565239
[TBL] [Abstract][Full Text] [Related]
8. Initial results of hypoxia imaging using 1-alpha-D: -(5-deoxy-5-[18F]-fluoroarabinofuranosyl)-2-nitroimidazole ( 18F-FAZA).
Postema EJ; McEwan AJ; Riauka TA; Kumar P; Richmond DA; Abrams DN; Wiebe LI
Eur J Nucl Med Mol Imaging; 2009 Oct; 36(10):1565-73. PubMed ID: 19430784
[TBL] [Abstract][Full Text] [Related]
9. Multiparametric imaging of patient and tumour heterogeneity in non-small-cell lung cancer: quantification of tumour hypoxia, metabolism and perfusion.
van Elmpt W; Zegers CML; Reymen B; Even AJG; Dingemans AC; Oellers M; Wildberger JE; Mottaghy FM; Das M; Troost EGC; Lambin P
Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):240-248. PubMed ID: 26338178
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia imaging agents labeled with positron emitters.
Hoigebazar L; Jeong JM
Recent Results Cancer Res; 2013; 194():285-99. PubMed ID: 22918765
[TBL] [Abstract][Full Text] [Related]
11. PET imaging of tumour hypoxia.
Padhani A
Cancer Imaging; 2006 Oct; 6(Spec No A):S117-21. PubMed ID: 17114063
[TBL] [Abstract][Full Text] [Related]
12. Dynamics of tumor hypoxia assessed by 18F-FAZA PET/CT in head and neck and lung cancer patients during chemoradiation: possible implications for radiotherapy treatment planning strategies.
Bollineni VR; Koole MJ; Pruim J; Brouwer CL; Wiegman EM; Groen HJ; Vlasman R; Halmos GB; Oosting SF; Langendijk JA; Widder J; Steenbakkers RJ
Radiother Oncol; 2014 Nov; 113(2):198-203. PubMed ID: 25434768
[TBL] [Abstract][Full Text] [Related]
13. Positron emission tomography radiotracers for imaging hypoxia.
Wuest M; Wuest F
J Labelled Comp Radiopharm; 2013; 56(3-4):244-50. PubMed ID: 24285331
[TBL] [Abstract][Full Text] [Related]
14. [Current Status and Prospects on PET Radiopharmaceuticals for Radiotherapy].
Yoshimoto M
Igaku Butsuri; 2015; 35(1):10-5. PubMed ID: 26753391
[TBL] [Abstract][Full Text] [Related]
15. Recent Advances of
Nguyen AT; Kim HK
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445730
[TBL] [Abstract][Full Text] [Related]
16. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
Vallabhajosula S
Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
[TBL] [Abstract][Full Text] [Related]
17. Positron emission tomography for radiation treatment planning.
Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M
Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216
[TBL] [Abstract][Full Text] [Related]
18. Imaging hypoxia in tumours with advanced MRI.
Price JM; Robinson SP; Koh DM
Q J Nucl Med Mol Imaging; 2013 Sep; 57(3):257-70. PubMed ID: 24045622
[TBL] [Abstract][Full Text] [Related]
19. PET hypoxia imaging with FAZA: reproducibility at baseline and during fractionated radiotherapy in tumour-bearing mice.
Busk M; Mortensen LS; Nordsmark M; Overgaard J; Jakobsen S; Hansen KV; Theil J; Kallehauge JF; D'Andrea FP; Steiniche T; Horsman MR
Eur J Nucl Med Mol Imaging; 2013 Jan; 40(2):186-97. PubMed ID: 23076620
[TBL] [Abstract][Full Text] [Related]
20. Biological imaging in radiation therapy: role of positron emission tomography.
Nestle U; Weber W; Hentschel M; Grosu AL
Phys Med Biol; 2009 Jan; 54(1):R1-25. PubMed ID: 19060363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
